Publicis acquires health analytics firm Verilogue
December 10, 2013Medical Communications Publicis Groupe, Veriogue, agency, comms
Publicis Groupe has acquired Verilogue, a healthcare analytics firm that specialises in doctor-patient communication. The US, Pennsylvania-based agency will now …
Cancer diagnosis is ‘national disgrace’
December 10, 2013Sales and Marketing CCGs, Cancer, NHS, appgc
Cancer care is still dangerously dependent on where patients in England live according to an influential group of MPs and …
Wii Fit Plus benefits patients with diabetes
December 10, 2013Medical Communications, Sales and Marketing bmc, diabetes, games, type 2, wii fit plus
A study says using interactive games through Nintendo’s Wii console helped type 2 diabetics to control their disease and improve …
J&J chooses UK as a new hub to ‘listen’ for innovation
December 10, 2013Research and Development, Sales and Marketing J&J, JJ, UK, innovation, research
Johnson & Johnson has chosen the UK as its formal European hub after announcing the creation of five new sites …
Nuevolution hires Takeda head as chief business officer
December 10, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, neuvolution
Small molecule lead discovery firm Nuevolution has poached Ton Berkien from Takeda to join the firm as a chief business …
Cancer Research: ‘Advert helped early diagnosis’
December 10, 2013Medical Communications, Sales and Marketing Cancer, be clear, cough, government
A TV campaign urging people with a persistent cough to visit their doctor has led to hundreds of people receiving …
FDA seeks top-to-toe review of Wockhardt manufacturing
December 9, 2013Manufacturing and Production AZ, GMP, Taylor, Wockhardt. fda
Wockhardt has been asked to undertake an assessment of its entire manufacturing processes, according to an FDA warning letter. Sent …
Pfizer cuts manufacturing again with plant closure
December 9, 2013Manufacturing and Production Ireland, Merck, Pfizer, Taylor, facility
A packaging plant in Ireland is the latest to come into the cross-hairs of the people at Pfizer tasked with …
CLL drug achieves ‘unprecedented’ remissions
December 9, 2013Research and Development, Sales and Marketing AbbVie, CML, Genentech, abt-199
AbbVie and Genentech’s investigational oncology drug ABT-199 has performed well in a Phase I trial for blood cancer, according to …
Gilead’s $1,000 per day Hep C drug approved
December 9, 2013Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi
Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …
API imports in the EU: gauging the FMD’s impact
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing API, EMA, FMD, Taylor, manufacturing, supply chain
The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …
Savara Pharmaceuticals appoints two board members
December 9, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph McCracken, Pikover, savara
Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …
EMA in new Iclusig probe
December 9, 2013Sales and Marketing Ariad, EMA, iclusig, leukaemia
Europe’s medicines regulator has begun a new review of Ariad Pharmaceuticals’ leukaemia drug Iclusig, looking in particular at the risk …
GSK launches cancer ‘consortium’
December 6, 2013Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research
GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
FleishmanHillard hires senior head from Edelman
December 6, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FleishmanHillard, tolk
Comms and PR global agency FleishmanHillard has appointed Jerry Tolk to be its senior VP, partner and general manager in …
NICE wants more Lemtrada data
December 6, 2013Sales and Marketing Lemtrada, MS, NICE, Sanofi
NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …
Court annuls EMA data decision
December 5, 2013Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency
The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …
New insulin scores for Sanofi
December 5, 2013Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300
Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
British Safety Council appoints new commercial director
December 5, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BSC, richard evens
Not-for-profit organisation The British Safety Council has appointed Richard Evens as its new commercial director. Evens will be responsible for …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
